Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCMA Challenges D.C.'s PBM "Transparency" Provision In Federal Court

This article was originally published in The Pink Sheet Daily

Executive Summary

The PBM association's arguments against Title II of D.C.'s "AccessRx Act of 2004" mirror those made in a similar case in Maine. PCMA contends that the law, which requires PBMs to disclose financial arrangements with drug manufacturers, is unconstitutional and preempted by ERISA.

You may also be interested in...



Express Scripts CEO Sees Transparency Law Consequences

PBMs are able to secure better prices from manufacturers without transparency, Paz says.

Express Scripts CEO Sees Transparency Law Consequences

PBMs are able to secure better prices from manufacturers without transparency, Paz says.

PCMA To Continue To Fight D.C. PBM Transparency Law

D.C. lawmakers attempt to lift injunction by revising transparency bill to resemble legislation from Maine.

Related Content

Topics

UsernamePublicRestriction

Register

ID014775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel